Effect of a non-peptide NK-2 tachykinin receptor antagonist on LH, FSH, and prolactin release by rat hemipituitaries in vitro

Journal of Physiology and Pharmacology

Volumn 48, Issue 3, 1997, Pages 461-478

  Debeljuk, L ^a   Bandera, R ^a   Bartke, A ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anterior pituitary; Castration; Neurokinin A; SR 48,968; Substance P; Tachykinins

Indexed keywords

ESTRADIOL; FOLLITROPIN; GONADORELIN; LUTEINIZING HORMONE; PROLACTIN; SAREDUTANT; TACHYKININ RECEPTOR ANTAGONIST; TESTOSTERONE; VERAPAMIL;

ADENOHYPOPHYSIS; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENANTIOMER; IN VITRO STUDY; NONHUMAN; OVARIECTOMY; PROLACTIN RELEASE; RAT; SECRETION;

ANIMALS; BENZAMIDES; CASTRATION; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; LUTEINIZING HORMONE; MALE; OVARIECTOMY; PIPERIDINES; PITUITARY GLAND, ANTERIOR; PROLACTIN; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, NEUROKININ-2; STEREOISOMERISM; TESTOSTERONE; VERAPAMIL;

EID: 0030802615     PISSN: 08675910     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Brown E, Harlan R, Krause JE. Gonadal steroid regulation of substance P (SP) and SP-encoding messenger ribonucleic acids in the rat anterior pituitary and hypothalamus. Endocrinology 1990; 126: 330-340.
2. Coslovsky R, Evans R, Leeman SE, Braverman L, Aronin N. The differential effects of thyroid and gonadal hormones on substance P content in the anterior pituitary of the prepubertal rat. Endocrinology 1984; 115: 2285-2289.
3. Debeljuk L, Ghosh P, Bartke A. Neurokinin A levels in the hypothalamus of rats and mice: Effects of castration, gonadal steroids and expression of heterologous growth hormone genes. Brain Res Bull 1990; 25: 717-721.
4. Debeljuk L, Lam EW, Bartke A. Effect of castration and sex steroids on neurokinin A concentrations in the anterior pituitary of male rats. Neuroendocrinol Lett 1991; 13: 5-14.
5. Jonassen J, Mullikin-Kilpatrick D, McAdam A, Leeman SE. Thyroid hormone status regulates preprotachykinin-A gene expression in male anterior pituitary. Endocrinology 1987; 121: 1555-1561.
6. Debeljuk L, Rao JN, Bartke A. Tachykinins and their gene expression in the anterior pituitary of the Siberian hamster-effects of photoperiod, thyroid hormones, and analogs of hypothalamic hormones. Endocrine 1995; 3: 839-843.
7. Vijayan E, McCann SM. In vivo and in vitro effects of substance P and neurotensin on gonadotropin and prolactin release. Endocrinology 1979; 105: 64-68.
8. Kalra PS, Sahu A, Bonavera JJ, Kalra SP. Diverse effects of tachykinins on luteinizing hormone release in male rats: mechanism of action. Endocrinology 1992; 131: 1195-1201.
9. Traczyk WZ, Pau KYF, Kaynard AH, Spies HG. Modulatory role of substance P on gonadotropin and prolactin secretion in the rabbit. J Physiol Pharmacol 1992; 43: 279-298.
10. Shamgochian MD, Leeman SE. Substance P stimulates luteinizing hormone secretion secretion from anterior pituitary cells in culture. Endocrinology 1991; 131: 871-875.
11. Brown ER, Roth K, Krause JE. Sexually dimorphic distribution of substance P in soecific anterior pituitary cells populations. Proc Nat Acad Sci USA 1991; 88: 1222-1226.
12. Larsen PJ, Saermark T, Mau SE. Binding of an iodinated substance P analogue to cultured anterior pituitary prolactin- and luteinizing hormone-containing cells. J Histochem Cytochem 1991; 40: 487-493.
13. Emonds-Alt X, Vilain P, Goulaouici P et al. A potent and selective non-peptide antagonist of the neurokinin A (NK2) receptor. Life Sci 1993; 50: PL-101-PL-106.
14. Desai MC, Lefhowitz SL, Thadeio PF, Longo KP, Snider RM. Discovery of a potent Substance P antagonist: Recognition of the key molecular determinant. J Med Chem 1991; 35: 4911-4913.
15. Emonds-Alt X, Golliot F, Pointeau P, Le Fur G, Breliére JC. Characterization of the binding sites of {3H}SR 48,968, a potent nonpeptide radioligand antagonist of the neurokinin-2 receptor. Biochem Biophys Res Commun 1993; 191: 1172-1177.
16. 2+ channels. Eur J Pharmacol 1992; 219: 491-492.
17. Constantine JW, Lebel WS, Woody HA, Benoit PA, Wolfgang EA, Knight DR. Cardiovascular effects of CP-96,345, a non-peptide blocker of tachykinin NK1 receptors. Eur J Pharmacol 1994; 252: 275-282.
18. 2+ channels. Eur J Pharmacol 1994; 267: 113-115.
19. Pisera D, Debeljuk L, Seilicovich A et al. Possible role of neurokinin A in the control of prolactin secretion in rats and hamsters. J Neuroendocrinol 1991; 3: 279-283.
20. Lafond J, Collu R. Role of calcium and sodium ions in the inhibitory control of baseline and stimulated prolactin release. Endocrinology 1986; 119: 2012-2017.
21. Drouva SV, Rerat E, Bihoreau C et al. Dihydropyridine-sensitive calcium channel activity related to prolactin, growth hormone, and luteinizing hormone release from anterior pituitary cells in culture: interactions with somatostatin, dopamine, and estrogens. Endocrinology 1998; 123: 2763-2773.
22. Houben H, Denef C. Unexpected effects of peptide and nonpeptide substance P receptor antagonists on basal prolactin and growth hormone release in vitro. Peptides 1993; 14: 109-115.